Wilson’s Disease Caused by Previously Undescribed Homozygous Nucleotide Variant of the ATP7B Gene: Clinical Cases
https://doi.org/10.15690/vsp.v23i2.2725
Abstract
Wilson’s disease is severe autosomal recessive disease manifested primarily by hepatic, neurological, and psychiatric disorders due to excessive copper deposition in organs and tissues. Clinical case description. The variant with uncertain clinical value of the ATP7B gene, c.2111C>T (p.T704I, chr13:52534294G>A (HG19)), was described in the family where parents are cousins. The eldest daughter out of four children died at the age of 11 due to liver cirrhosis. Wilson’s disease was genetically confirmed in two children (clinically — abdominal form). The younger son was diagnosed heterozygous state of the disease (without any clinical manifestations). The revealed variant of the ATP7B gene was previously identified in 3 more patients with Wilson’s disease, however, in a compound heterozygous state with known pathogenic genetic variant. Conclusion. c.2111C>T (p.T704I) variant of the ATP7B gene can be considered as probably pathogenic. Further research is required to evaluate its functional significance in Wilson’s disease pathogenesis.
About the Authors
Denis K. ChernevskiyRussian Federation
Nizhny Novgorod; Moscow
Disclosure of interest:
None
Alla E. Lavrova
Russian Federation
Nizhny Novgorod
Disclosure of interest:
None
Ekaterina Yu. Konovalova
Russian Federation
Nizhny Novgorod
Disclosure of interest:
None
Elena Yu. Borisova
Russian Federation
Nizhny Novgorod
Disclosure of interest:
None
Natalia A. Doroshchuk
Russian Federation
Moscow
Disclosure of interest:
None
Olga S. Groznova
Russian Federation
Moscow
Disclosure of interest:
None
References
1. Trocello JM, Broussolle E, Girardot-Tinant N, et al. Wilson’s disease, 100 years later… Rev Neurol (Paris). 2013;169(12):936–943. doi: https//doi.org/10.1016/j.neurol.2013.05.002
2. Weiss KH, Schilsky M. Wilson Disease. 1999 Oct 22 [updated 2023 Jan 12]. In: GeneReviews® [Internet]. Adam MP, Mirzaa GM, Pagon RA, et al., eds. Seattle (WA): University of Washington, Seattle; 1993–2023.
3. Gomes A, Dedoussis GV. Geographic distribution of ATP7B mutations in Wilson disease. Ann Hum Biol. 2016;43(1):1–8. doi: https//doi.org/10.3109/03014460.2015.1051492
4. Bayazutdinova GM, Shchagina OA, Polyakov AV, et al. Spectrum of Mutations in the ATP7B Gene in Russian Patients with Wilson’s. Russian Journal of Genetics. 2019;55(12):1433–1441. (In Russ). doi: https//doi.org/10.1134/S0016675819120026
5. Mulligan C, Bronstein JM. Wilson Disease: An Overview and Approach to Management. Neurol Clin. 2020;38(2):417–432. doi: https//doi.org/10.1016/j.ncl.2020.01.005
6. Luzina EV, Yemelyanova ON, Shcherbak VA, et al. Wilson’s disease: a review of clinical guidelines, literature and a case report. Experimental and Clinical Gastroenterology. 2022;(7):239–245. (In Russ). doi: https://doi.org/10.31146/1682-8658-ecg-203-7-239-245
7. Członkowska A, Litwin T, Dusek P, et al. Wilson disease. Nat Rev Dis Primers. 2018;4(1):21. doi: https://doi.org/10.1038/s41572-018-0018-3
8. Narusheniya obmena medi (bolezn’ Vil’sona): Clinical Guidelines. Association of Medical Genetics; Union of Pediatricians of Russia; Non-profit Partnership “National Society for the Study of Parkinson’s Disease and Movement Disorders”; Russian Transplant Society; Autonomous non-profit organization “Society of Pediatric Gastroenterologists, Hepatologists and Nutritionists”; National Association of Children’s Rehabilitologists. Ministry of Health of Russia; 2021. 66 p. (In Russ).
9. European Association for Study of Liver. EASL Clinical Practice Guidelines: Wilson’s disease. J Hepatol. 2012;56(3):671–685. doi: https://doi.org/10.1016/j.jhep.2011.11.007
10. Saroli Palumbo C, Schilsky ML. Clinical practice guidelines in Wilson disease. Ann Transl Med. 2019;7(Suppl 2):S65. doi: https://doi.org/10.21037/atm.2018.12.53
11. Koboldt DC, Hickey SE, Chaudhari BP, et al. Early-onset Wilson disease caused by ATP7B exon skipping associated with intronic variant. Cold Spring Harb Mol Case Stud. 2020;6(3):a005306. doi: https://doi.org/10.1101/mcs.a005306
12. Xu WQ, Wang RM, Dong Y, Wu ZY. Pathogenicity of Intronic and Synonymous Variants of ATP7B in Wilson Disease. J Mol Diagn. 2023;25(1):57–67. doi: https://doi.org/10.1016/j.jmoldx.2022.10.002
13. Kerkar N, Rana A. Wilson Disease in Children. Clin Liver Dis. 2022;26(3):473–488. doi: https://doi.org/10.1016/j.cld.2022.03.008
14. De Rycke M, Berckmoes V. Preimplantation Genetic Testing for Monogenic Disorders. Genes (Basel). 2020;11(8):871. doi: https://doi.org/10.3390/genes11080871
15. Li M, Ma J, Wang W, et al. Mutation analysis of the ATP7B gene and genotype-phenotype correlation in Chinese patients with Wilson disease. BMC Gastroenterol. 2021;21(1):339. doi: https://doi.org/10.1186/s12876-021-01911-5
16. Bennett RL, French KS, Resta RG, Austin J. Practice resource-focused revision: Standardized pedigree nomenclature update centered on sex and gender inclusivity: A practice resource of the National Society of Genetic Counselors. J Genet Couns. 2022;31(6):1238–1248. doi: https://doi.org/10.1002/jgc4.1621
17. Variant chr13-52534294-G-A. In: Varsome. Available online: https://varsome.com/variant/hg19/chr13-52534294-G-A?annotation-mode=germline. Accessed on January 08, 2024.
18. Variant T704I. In: WilsonGen. Available online: https://clingen. igib.res.in/WilsonGen/showdata.php?id=5e9b367b3a6e8b628a865239&hgvs_id=&Start=52534294&Alt=A&Ref=G&chr=chr13. Accessed on January 08, 2024.
19. Li X, Lu Z, Lin Y, et al. Clinical features and mutational analysis in 114 young children with Wilson disease from South China. Am J Med Genet A. 2019;179(8):1451–1458. doi: https://doi.org/10.1002/ajmg.a.61254
20. Huang C, Fang M, Xiao X, et al. Genetic studies discover novel coding and non-coding mutations in patients with Wilson’s disease in China. J Clin Lab Anal. 2022;36(6):e24459. doi: https://doi.org/10.1002/jcla.24459
21. Feng CX, Chen XQ, He XL, et al. Screening for Wilson’s disease in acute liver failure: A new scoring system in children. Front Pediatr. 2022;10:1003887. doi: https://doi.org/10.3389/fped.2022.1003887
22. Woimant F, Poujois A, Bloch A, et al. A novel deep intronic variant in ATP7B in five unrelated families affected by Wilson disease. Mol Genet Genomic Med. 2020;8(10):e1428. doi: https://doi.org/10.1002/mgg3.1428
23. Stalke A, Behrendt A, Hennig F, et al. Functional characterization of novel or yet uncharacterized ATP7B missense variants detected in patients with clinical Wilson’s disease. Clin Genet. 2023;104(2):174–185. doi: https://doi.org/10.1111/cge.14352
24. Tang S, Bai L, Zheng SJ. Zhonghua Gan Zang Bing Za Zhi. 2021;29(1):21–24. doi: https://doi.org/10.3760/cma.j.cn501113-20201104-00598
25. Cai H, Cheng X, Wang XP. ATP7B gene therapy of autologous reprogrammed hepatocytes alleviates copper accumulation in a mouse model of Wilson’s disease. Hepatology. 2022;76(4):1046–1057. doi: https://doi.org/10.1002/hep.32484
26. Bittles AH, Black ML. Evolution in health and medicine Sackler colloquium: Consanguinity, human evolution, and complex diseases. Proc Natl Acad Sci U S A. 2010;107(Suppl 1):1779–1786. doi: https://doi.org/10.1073/pnas.0906079106
27. Bennett RL, Malleda NR, Byers PH, et al. Genetic counseling and screening of consanguineous couples and their offspring practice resource: Focused Revision. J Genet Couns. 2021;30(5):1354–1357. doi: https://doi.org/10.1002/jgc4.1477
Review
For citations:
Chernevskiy D.K., Lavrova A.E., Konovalova E.Yu., Borisova E.Yu., Doroshchuk N.A., Groznova O.S. Wilson’s Disease Caused by Previously Undescribed Homozygous Nucleotide Variant of the ATP7B Gene: Clinical Cases. Current Pediatrics. 2024;23(2):104-110. (In Russ.) https://doi.org/10.15690/vsp.v23i2.2725